Hexter Joshua bought ORMP

July 2, 2026 · Form 4 insider transaction

Hexter Joshua bought 50,000 shares of Oramed Pharmaceuticals Inc. at $3.69 per share, a transaction worth $184.5K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 0 days after the transaction.